About Tomas Heyman
Form D filings for Venatorx Pharmaceuticals in 2023 list Tomas Heyman as director.
Tomas Heyman first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Tomas Heyman in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Tomas Heyman works with at each company, as listed on that company's latest Form D.
Venatorx Pharmaceuticals, Inc. · Form D/A, Jul 13, 2023
TH
Timothy Haines
Director
CB
Christopher Burns
President and director
DP
Daniel Pevear
Executive officer
AM
Anthony Meehan
Executive officer
SP
Sergei Petukhov
Director
MH
Martin Heidecker
Director